Associations of activated coagulation factor VII and factor VIIa‐antithrombin levels with genome‐wide polymorphisms and cardiovascular disease risk

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|16|1|19-30

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.16, Iss.1, 2018-01, pp. : 19-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : 670-680

John Wiley & Sons Inc

Access to resources Recommend Favorite

The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : 670-680

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased plasma levels of activated factor VII in patients with deep vein thrombosis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 7, 2015-07 ,pp. : 1320-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activated Recombinant Human Coagulation Factor VII Therapy for Intracranial Hemorrhage in Patients with Hemophilia A or B with Inhibitors

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 93-98

Karger

Access to resources Recommend Favorite

Recombinant activated factor VII in paediatric cardiac surgery

By Egan Jonathan   Lammi Ahti   Schell David   Gillis Jonathan   Nunn Graham  

Intensive Care Medicine, Vol. 30, Iss. 4, 2004-04 ,pp. : 682-685

Springer Publishing Company

Access to resources Recommend Favorite